The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Learn how Portugal’s biotech and life sciences ecosystem is advancing research, startups, and innovation even amid funding ...

New Jersey has long been one of the core hubs of the U.S. pharmaceutical industry, home to biotech companies such as Johnson & Johnson and Merck, as well as a dense network of research and development ...

3B Pharmaceuticals is developing both therapeutic and diagnostic radiopharmaceuticals for oncology applications. The focus of its drug development programs is a theranostic approach using diagnostic ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

The news that the organization led a $35 million funding round for London-based Portal Biotech came about two weeks ago. Portal Biotech’s focus is on the field of proteomics, which is the study of ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...